首页> 外文期刊>Chemistry central journal >Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles
【24h】

Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles

机译:多种抗原呈递肽疫苗系统的现状:有机和无机纳米粒子的应用

获取原文
           

摘要

Many studies are currently investigating the development of safe and effective vaccines to prevent various infectious diseases. Multiple antigen-presenting peptide vaccine systems have been developed to avoid the adverse effects associated with conventional vaccines (i.e., live-attenuated, killed or inactivated pathogens), carrier proteins and cytotoxic adjuvants. Recently, two main approaches have been used to develop multiple antigen-presenting peptide vaccine systems: (1) the addition of functional components, e.g., T-cell epitopes, cell-penetrating peptides, and lipophilic moieties; and (2) synthetic approaches using size-defined nanomaterials, e.g., self-assembling peptides, non-peptidic dendrimers, and gold nanoparticles, as antigen-displaying platforms. This review summarizes the recent experimental studies directed to the development of multiple antigen-presenting peptide vaccine systems.
机译:当前,许多研究正在研究开发安全有效的疫苗以预防各种传染病。已经开发了多种抗原呈递肽疫苗系统,以避免与常规疫苗(即减毒,灭活或灭活的病原体),载体蛋白和细胞毒性佐剂相关的不利影响。最近,已经使用两种主要方法来开发多种抗原呈递肽疫苗系统:(1)添加功能性成分,例如T细胞表位,细胞穿透性肽和亲脂性部分; (2)使用尺寸确定的纳米材料(例如自组装肽,非肽树状聚合物和金纳米颗粒)作为抗原展示平台的合成方法。这篇综述总结了针对开发多种抗原呈递肽疫苗系统的最新实验研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号